Results · Apr-Jun 2026
Omkar Pharmachem Q1 FY27 results
Sales fell 33% to ₹0.09 crore from ₹0.14 crore in Apr-Jun 2025.
Operating profit fell 126% to −₹0.01 crore, an operating margin of −10.7% (down 37.8 points from a year ago).
Net profit turned into a loss of ₹0.01 crore, from a profit of ₹0.03 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +0%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.1 | 0.1 | −33% |
| Operating profit (EBITDA) | -0.0 | 0.0 | −126% |
| Operating margin | −10.7% | 27.1% | −37.8 pts |
| Net profit | -0.0 | 0.0 | swings to a loss |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.